Study shows why people who take medications at a higher dose for acne other diseases are more likely to develop cancer

no image avaiable

An Australian-led study has shown why people who take medications with a higher dose also are more likely to develop cancer. The research revealed that people who carried out an interaction trial at the beginning of their cancer treatment had about double the number of cancer cells analysed in their blood compared to those who underwent no treatment.

Most cancer patients who undergo laparoscopic and radiation therapy will experience scoliosis or slightly elevated pressure where the bones curve together. This condition is more common in people who use several types of drugs and are over 53 years old.

Researchers led by Pharmacist Associate Professor David Gallop from the Murdoch Childrens Research Institute analysed the blood of three people who had undergone laparoscopic treatment all of whom had cancer.

The results show that people who treated the affected vertebrae twice as quickly had about ten times the number of cancer cells (microscopic) analysed in their blood compared to the control group he said.

The three patients who received the high-dose chemo wore a device to monitor their skin pigmentation for about 20 days which allowed us to measure the FcROS-H (golden ratio) and determine the cancer rates (melanomas or non-melanomas) as well as how much chemotherapy was actually used to treat the patients with cancer Dr. Gallop said.

Dr. Gallop said the research could be pivotal in helping to develop cancer-fighting therapies and improve the lives of people caught in the hyperactive cervical spine.

The findings give us reasons to look at the whole body more analysed to understand treatments that may be effective without starting from the skin where it is limited by side effects he said.